NASD
| Health Care |
Biotechnology
DBV Technologies SA (DBVT)
LAST (8 Apr)
Pre-Market (07:15:42 ET)
MARKET CAP
VOLUME
| Open | 7.20 |
| Previous Close | 7.44 |
| Day Range | 6.93 - 7.49 |
| 52-Week Range | 2.20 - 8.50 |
| All-Time High | 505.70 |
| Avg. Volume (50-day) | 491,913.03 |
| EPS (TTM) | -5.85 |
| Next Earnings Date | 2025-05-07 |
| Last Earnings Date | 2025-03-24 |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | No |
| P/E Ratio | -1.27 |
| PEG Ratio | - |
| Price to Book | 2.65 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | - |
| Revenue per Share (TTM) | - |
| Shares Outstanding | 20.512 M |
| Share Float (%) | 20.50 M |
| % Held by Institutions | 120.29 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 5.9 (+21.10%) |
| +/- SMA(50) | 4.81 (+48.54%) |
| +/- SMA(200) | 4.13 (+73.00%) |
| 5-Day Perf. | +10.6% |
| 1-Month Perf. | +71.12% |
| 3-Month Perf. | +86.55% |
| 6-Month Perf. | +99.78% |
| YTD Perf. | +131.23% |
| 1-Year Perf. | -7.22% |
| RSI(14) | 61.48 |
| ATR(14) | 0.88 |
| ADX(14) | 39.39 |
| Beta (5Y) | 0.77 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
DBVT
DBV Technologies SA
177-181, avenue Pierre Brossolette, 107 avenue de la Republique
Chatillon, Hauts-de-France
http://www.dbv-technologies...
Sector: Health Care
Industry: Biotechnology
Employees:
Description
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
DBVT has triggered the following predefined scans:
| Bearish Harami |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
